Skip to main content

Anika Therapeutics, Inc 10-K for FY2025

Anika Therapeutics, Inc. (ANIK)

10-K 2026-03-03 For: 2025-12-31
View Original
Added on April 06, 2026

About this 10-K

Anika Therapeutics, Inc filed this 10-K on March 3, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$112.82M
down 5.9% from $119.91M a year earlier
Net loss
$10.88M
compared with a net loss of $56.39M a year earlier
Diluted EPS
-$0.76
compared with -$3.83 a year earlier